Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Article Type
Date
Availability
1-8 of 8
Keywords: Hepatic fibrosis
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2024) 138 (5): 327–349.
Published: 05 March 2024
...Mitsuyoshi Yamagata; Mutsumi Tsuchishima; Takashi Saito; Mikihiro Tsutsumi; Joseph George Metabolic dysfunction-associated steatohepatitis (MASH) is always accompanied with hepatic fibrosis that could potentially progress to liver cirrhosis and hepatocellular carcinoma. Employing a rat model, we...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2021) 135 (24): 2665.
Published: 15 December 2021
... Alamandine Angiotensin II Hepatic fibrosis NADPH oxidase Oxidative stress This Correction follows an Expression of Concern relating to this article previously published by Portland Press. © 2021 The Author(s). 2021 This is an open access article published by Portland Press...
Includes: Supplementary data
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2020) 134 (13): 1675.
Published: 06 July 2020
... © 2020 The Author(s). 2020 This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) . Alamandine Angiotensin II Autophagy Hepatic fibrosis NADPH oxidase...
Articles
Yun Huang, Yang Li, Anni Lou, Guo zhen Wang, Ye Hu, Yijie Zhang, Weichang Huang, Jun Wang, Yue Li, Xintao Zhu, Tingting Chen, Jiayi Lin, Ying Meng, Xu Li
Journal:
Clinical Science
Clin Sci (Lond) (2020) 134 (7): 853–869.
Published: 09 April 2020
...Yun Huang; Yang Li; Anni Lou; Guo zhen Wang; Ye Hu; Yijie Zhang; Weichang Huang; Jun Wang; Yue Li; Xintao Zhu; Tingting Chen; Jiayi Lin; Ying Meng; Xu Li Angiotensin II (Ang II) has been reported to aggravate hepatic fibrosis by inducing NADPH oxidase (NOX)-dependent oxidative stress. Alamandine...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2016) 130 (16): 1469–1480.
Published: 07 July 2016
... sequence against miR-21 was constructed to reduce miR-21 expression efficiently in vitro and in vivo . Histological and immunohistological examinations were performed to evaluate the inhibitory effects and mechanism of Ad-TuD-21 delivery into carbon tetrachloride (CCl 4 ) induced hepatic fibrosis rats...
Includes: Supplementary data
Articles
Maria Luisa Balmer, Jeannine Joneli, Alain Schoepfer, Felix Stickel, Wolfgang Thormann, Jean-François Dufour
Journal:
Clinical Science
Clin Sci (Lond) (2010) 119 (10): 431–436.
Published: 05 August 2010
...). Adiponectin levels were decreased in patients with NAFLD. In conclusion, adiponectin levels correlate positively with surrogate markers of hepatic fibrosis (transient elastography, fasting serum bile acids and hyaluronate) and are significantly elevated in cases of cirrhosis. From 1 January 2006 to 31...
Includes: Supplementary data
Articles
John S. Lubel, Chandana B. Herath, Jorge Tchongue, Josephine Grace, Zhiyuan Jia, Karen Spencer, David Casley, Peter Crowley, William Sievert, Louise M. Burrell, Peter W. Angus
Journal:
Clinical Science
Clin Sci (Lond) (2009) 117 (11): 375–386.
Published: 14 September 2009
... was pharmacologically inhibited [ 19 ]. However, to date, there has been no direct evidence that administration of the Ang-(1–7) peptide can influence hepatic fibrosis in animal models nor has there been confirmation that circulating levels of this peptide are increased in human liver disease. In this present study, we...
Includes: Supplementary data
Articles
Paula MAYORAL, Manuela CRIADO, Froilan HIDALGO, Olga FLORES, Miguel A. ARÉVALO, Nélida ELENO, Angel SÁNCHEZ-RODRÍGUEZ, Jose M. LÓPEZ-NOVOA, Alejandro ESTELLER
Journal:
Clinical Science
Clin Sci (Lond) (1999) 96 (3): 297–305.
Published: 01 March 1999
...Paula MAYORAL; Manuela CRIADO; Froilan HIDALGO; Olga FLORES; Miguel A. ARÉVALO; Nélida ELENO; Angel SÁNCHEZ-RODRÍGUEZ; Jose M. LÓPEZ-NOVOA; Alejandro ESTELLER Hepatic fibrosis or increased liver collagen contents drive functional abnormalities that, when extensive, may be life threatening...